Nayler W G, Fassold E, Yepez C
Cardiovasc Res. 1978 Mar;12(3):152-61. doi: 10.1093/cvr/12.3.152.
Experiments were undertaken to determine if drugs (verapamil, propranolol, and methylprednisolone sodium saccinate) that protect the fine ultrastructure of heart muscle against damage caused by hypoxia, protect mitochondrial function. Mitochondrial function was assessed in terms of oxidative phosphorylating and Ca2 +-accumulating activities. Isolated rabbit hearts were used, and hypoxic conditions induced by reducing the perfusate PO2 from 80.8 to 0.80 kPa (600 to 6 mmHg). The drugs were either added at the start of the hypoxic perfusion or (verapamil and propranolol) the rabbits were pretreated with them. Verapamil, propranolol and, to a lesser extent, methylprednisolone sodium succinate, provided protection evidenced by the maintainance of near normal mitochondrial oxidative phosphorylating and Ca2 +-accumulating activities after 60 min hypoxic perfusion. When added directly to mitochondria isolated from hypoxic-perfused muscle, the drugs had no effect.
进行实验以确定保护心肌精细超微结构免受缺氧损伤的药物(维拉帕米、普萘洛尔和琥珀酸钠甲泼尼龙)是否能保护线粒体功能。线粒体功能根据氧化磷酸化和钙离子积累活性进行评估。使用离体兔心脏,通过将灌注液的氧分压从80.8kPa降至0.80kPa(600mmHg降至6mmHg)来诱导缺氧条件。药物要么在缺氧灌注开始时添加,要么(维拉帕米和普萘洛尔)对兔子进行预处理。维拉帕米、普萘洛尔以及程度稍轻的琥珀酸钠甲泼尼龙提供了保护作用,表现为在缺氧灌注60分钟后线粒体氧化磷酸化和钙离子积累活性维持在接近正常水平。当直接添加到从缺氧灌注肌肉分离的线粒体中时,这些药物没有效果。